ARCHIVES

NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted

This article is from The Cancer Letter archive.

Vol. 02 No. 12 | March 19, 1976

Download PDF Visit The Full Archive

Related Articles

Bunn Says ASCO Is “Strong, Diverse, Respected, Growing”

June 6, 2003

Includes May Business & Regulatory Report (8-page issue).

June 6, 2003

AACI Recommends Cancer Control Guideline Changes

February 9, 1979

Oral Capecitabine Equal To 5FU-Leucovorin In Adjuvant Stage III Colon Cancer Treatment

June 25, 2004

NYC Doctor Pays $2.35 Million To Settle False Claims Act Suit Over Radiosurgery Reimbursements

December 5, 2014

Panel Urges Research On DCIS To Identify Women At High Risk For Invasive Cancer

September 25, 2009